Waystar (WAY) Set to Announce Earnings on Monday

Waystar (NASDAQ:WAY) will likely be releasing its Q3 2026 results after the market closes on Monday, November 2nd. Analysts expect Waystar to announce earnings of $0.4072 per share and revenue of $323.42 million for the quarter. Parties may visit the company’s upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Monday, November 2, 2026 at 4:30 PM ET.

Waystar (NASDAQ:WAY) last issued its quarterly earnings data on Wednesday, July 29th. The company reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.03. Waystar had a return on equity of 7.03% and a net margin of 11.18%. The business had revenue of $319.67 million during the quarter, compared to analysts’ expectations of $316.21 million. During the same quarter in the previous year, the firm posted $0.36 EPS. The company’s revenue for the quarter was up 18.1% on a year-over-year basis. On average, analysts expect Waystar to post $1.47 EPS for the current fiscal year and $1.68 EPS for the next fiscal year.

Waystar Price Performance

Shares of WAY opened at $28.85 on Monday. The company has a market capitalization of $5.53 billion, a price-to-earnings ratio of 41.21, a PEG ratio of 1.12 and a beta of 0.18. Waystar has a 52 week low of $17.26 and a 52 week high of $40.35. The stock’s 50-day moving average price is $25.80 and its 200-day moving average price is $23.10. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.36.

Insider Buying and Selling at Waystar

In related news, CEO Matthew Hawkins sold 82,500 shares of the company’s stock in a transaction dated Tuesday, October 6th. The stock was sold at an average price of $26.23, for a total value of $2,163,975.00. Following the completion of the transaction, the chief executive officer owned 1,804,794 shares of the company’s stock, valued at approximately $47,339,746.62. This represents a 4.37% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 247,500 shares of company stock valued at $6,370,499. 3.50% of the stock is owned by insiders.

Analyst Ratings Changes

Several research firms have commented on WAY. UBS Group lowered their price objective on Waystar from $37.00 to $33.00 and set a “buy” rating on the stock in a research report on Thursday, July 30th. Barclays lowered shares of Waystar from an “overweight” rating to an “equal weight” rating and lifted their target price for the company from $27.00 to $30.00 in a report on Tuesday, September 15th. BMO Capital Markets reiterated an “outperform” rating on shares of Waystar in a research note on Thursday, August 27th. Royal Bank Of Canada reiterated an “outperform” rating on shares of Waystar in a research note on Tuesday, September 15th. Finally, KeyCorp increased their price target on shares of Waystar from $30.00 to $35.00 and gave the stock an “overweight” rating in a report on Friday, October 16th. Two equities research analysts have rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $34.90.

Waystar Company Profile

Waystar Holding Corp. is a healthcare technology company that provides cloud-based software designed to simplify administrative and financial processes across the healthcare industry. Its platform connects healthcare providers, health plans and patients, helping organizations manage revenue cycle operations and improve the flow of information and payments.

The company’s products and services include electronic claims management, eligibility and benefits verification, prior authorization, payment integrity, denial management, patient estimates and payments, billing automation, and healthcare analytics.